Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes

被引:99
作者
Fukushima, Arata [1 ]
Lopaschuk, Gary D. [1 ]
机构
[1] Univ Alberta, Cardiovasc Translat Sci Inst, Edmonton, AB, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2016年 / 1861卷 / 10期
关键词
Obesity; Diabetes; Heart failure; Insulin resistance; Lysine acetylation; MALONYL-COA DECARBOXYLASE; MYOCARDIAL SUBSTRATE METABOLISM; ALPHA PPAR-ALPHA; PROTEIN LYSINE ACETYLATION; INDUCED INSULIN-RESISTANCE; COENZYME-A THIOLASE; GLUCOSE-OXIDATION; SKELETAL-MUSCLE; PRESSURE-OVERLOAD; ENERGY-METABOLISM;
D O I
10.1016/j.bbalip.2016.03.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity and diabetes are major public health problems, and are linked to the development of heart failure. Emerging data highlight the importance of alterations in cardiac energy metabolism as a major contributor to cardiac dysfunction related to obesity and diabetes. Increased rates of fatty acid oxidation and decreased rates of glucose utilization are two prominent changes in cardiac energy metabolism that occur in obesity and diabetes. This metabolic profile is probably both a cause and consequence of a prominent cardiac insulin resistance, which is accompanied by a decrease in both cardiac function and efficiency, and by the accumulation of potentially toxic lipid metabolites in the heart that can further exaggerate insulin resistance and cardiac dysfunction. The high cardiac fatty acid oxidation rates seen in obesity and diabetes are attributable to several factors, including: 1) increased fatty acid supply and uptake into the cardiomyocyte, 2) increased transcription of fatty acid metabolic enzymes, 3) decreased allosteric control of mitochondrial fatty acid uptake and fatty acid oxidation, and 4) increased post-translational acetylation control of various fatty acid oxidative enzymes. Emerging evidence suggests that therapeutic approaches aimed at switching the balance of cardiac energy substrate preference from fatty acid oxidation to glucose use can prevent cardiac dysfunction associated with obesity and diabetes. Modulating acetylation control of fatty acid oxidative enzymes is also a potentially attractive strategy, although presently this is limited to precursors of nicotinamide adenine or nonspecific activators of deacetylation such as resveratrol. This review will focus on the metabolic alterations in the heart that occur in obesity and diabetes, as well as on the molecular mechanisms controlling these metabolic changes. This article is part of a Special Issue entitled: Heart Lipid Metabolism edited by G.D. Lopaschuk. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:1525 / 1534
页数:10
相关论文
共 158 条
[1]   Insulin Resistance: Metabolic Mechanisms and Consequences in the Heart [J].
Abel, E. Dale ;
O'Shea, Karen M. ;
Ramasamy, Ravichandran .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (09) :2068-2076
[2]   Ceramide content is increased in skeletal muscle from obese insulin-resistant humans [J].
Adams, JM ;
Pratipanawatr, T ;
Berria, R ;
Wang, E ;
DeFronzo, RA ;
Sullards, MC ;
Mandarino, LJ .
DIABETES, 2004, 53 (01) :25-31
[3]   Plasma Acylcarnitine Profiles Suggest Incomplete Long-Chain Fatty Acid β-Oxidation and Altered Tricarboxylic Acid Cycle Activity in Type 2 Diabetic African-American Women [J].
Adams, Sean H. ;
Hoppel, Charles L. ;
Lok, Kerry H. ;
Zhao, Ling ;
Wong, Scott W. ;
Minkler, Paul E. ;
Hwang, Daniel H. ;
Newman, John W. ;
Garvey, W. Timothy .
JOURNAL OF NUTRITION, 2009, 139 (06) :1073-1081
[4]   Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction - The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial [J].
Aguilar, D ;
Solomon, SD ;
Kober, L ;
Rouleau, JL ;
Skali, H ;
McMurray, JJV ;
Francis, GS ;
Henis, M ;
O'Connor, CM ;
Diaz, R ;
Belenkov, YN ;
Varshavsky, S ;
Leimberger, JD ;
Velazquez, EJ ;
Califf, RM ;
Pfeffer, MA .
CIRCULATION, 2004, 110 (12) :1572-1578
[5]   Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling [J].
Alrob, Osama Abo ;
Sankaralingam, Sowndramalingam ;
Ma, Cary ;
Wagg, Cory S. ;
Fillmore, Natasha ;
Jaswal, Jagdip S. ;
Sack, Michael N. ;
Lehner, Richard ;
Gupta, Mahesh P. ;
Michelakis, Evangelos D. ;
Padwal, Raj S. ;
Johnstone, David E. ;
Sharma, Arya M. ;
Lopaschuk, Gary D. .
CARDIOVASCULAR RESEARCH, 2014, 103 (04) :485-497
[6]   Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels [J].
Anderson, RM ;
Bitterman, KJ ;
Wood, JG ;
Medvedik, O ;
Cohen, H ;
Lin, SS ;
Manchester, JK ;
Gordon, JI ;
Sinclair, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (21) :18881-18890
[7]   Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα) [J].
Aoyama, T ;
Peters, JM ;
Iritani, N ;
Nakajima, T ;
Furihata, K ;
Hashimoto, T ;
Gonzalez, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) :5678-5684
[8]   Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats [J].
Atkinson, LL ;
Kozak, R ;
Kelly, SE ;
Onay-Besikci, A ;
Russell, JC ;
Lopaschuk, GD .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (05) :E923-E930
[9]   Regulation of Ca2+ and Na+ in normal and failing cardiac myocytes [J].
Bers, Donald M. ;
Despa, Sanda ;
Bossuyt, Julie .
INTERACTIVE AND INTEGRATIVE CARDIOLOGY, 2006, 1080 :165-177
[10]   Sirtuin 3 (SIRT3) Protein Regulates Long-chain Acyl-CoA Dehydrogenase by Deacetylating Conserved Lysines Near the Active Site [J].
Bharathi, Sivakama S. ;
Zhang, Yuxun ;
Mohsen, Al-Walid ;
Uppala, Radha ;
Balasubramani, Manimalha ;
Schreiber, Emanuel ;
Uechi, Guy ;
Beck, Megan E. ;
Rardin, Matthew J. ;
Vockley, Jerry ;
Verdin, Eric ;
Gibson, Bradford W. ;
Hirschey, Matthew D. ;
Goetzman, Eric S. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (47) :33837-33847